Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,823,713 papers from all fields of science
Search
Sign In
Create Free Account
Alendronic acid 70 MG Oral Tablet [Fosamax]
Known as:
ALENDRONATE SODIUM 70 mg ORAL TABLET [FOSAMAX]
, FOSAMAX 70 MG Oral Tablet
, Fosamax 70 MG (as alendronate sodium 91.4 MG) Oral Tablet
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Alendronate Sodium
Alendronic acid
Croscarmellose Sodium
Fosamax
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Caso clínico de osteonecrosis de los maxilares: la trampa de los bifosfonatos
I. D. L. M. García
,
Marta Monteserín Matesanz
2013
Corpus ID: 191254785
Se presenta el caso de una paciente de 72 anos que desarrolla un cuadro de osteonecrosis maxilar posteriormente a la colocacion y…
Expand
2012
2012
골다공증 환자에 대한 Fosamax 단독복용군과 삼기음가미방 병용투여군의 유효성 비교분석
유성진
,
안희빈
,
김지영
,
이동녕
2012
Corpus ID: 78359602
2010
2010
Laagenergetische femurfractuur na langdurig bisfosfonaatgebruik
D. V. Kampen
,
A. V. D. Zwan
,
W. Willems
2010
Corpus ID: 71433450
Een 60-jarige Amerikaanse had een cruise geboekt door Europa, en struikelde bij het aan boord gaan van het cruiseschip in de…
Expand
Review
2008
Review
2008
Herbal Supplements (Haematanics) and their Interactions with Medications: An Overview
A. Dwivedi
2008
Corpus ID: 55575559
Herbal supplements, if taken at the same time as prescription medicines, can create potential problems for the user…
Expand
2008
2008
Merck Signs Osteoporosis Deal with Japan Tobacco
Taskin Ahmed
2008
Corpus ID: 72182216
Since Merck’s patent for Fosamax® (alendronate) expired in early 2008, the company has been seeking to fill the gap in its…
Expand
2007
2007
Ostéonécrose maxillaire due aux bisphosphonates. Recommandations diagnostiques et thérapeutiques
A. Robertson
,
Marius E. Kraenzlin
,
Hf Zeilhofer
,
C. Meier
2007
Corpus ID: 79608171
Les bisphosphonates sont utilisés dans l’ostéoporose depuis plus de vingt ans en raison de leur puissant effet inhibiteur sur les…
Expand
2007
2007
Bisphosphonatassoziierte Osteonekrose des Kiefers Empfehlungen zu Abklärung und Behandlung
A. Robertson
,
M. Kraenzlin
,
H. Zeilhofer
,
C. Meier
2007
Corpus ID: 163821681
Bisphosphonate werden dank ihrer potenten inhibitorischen Wirkung auf knochenresorbierende Osteoklasten seit uber 20 Jahren bei…
Expand
2004
2004
A Study of Bioactive Ceramic Ca2P2O7 with Na4P2O7 ̇10H2O Addition on Treatment of Osteoporosis
計畫編號NSC 92-2314-B
2004
Corpus ID: 17843175
Osteoporosis is a disease with clinical symptoms of bone mass loss and deterioration of microarchitecture on body skeleton, which…
Expand
2003
2003
Patients on bisphosphonates should not be at increased risk for hypocalcemic-induced tetany when given fleet® phosphosoda®
Marion O. Frincis
,
M. Caswell
Diseases of the Colon & Rectum
2003
Corpus ID: 44448128
To the Editor—In their 1999 case report, Campisi and colleagues1 advised caution in prescribing Fleet® Phospho-soda® (CB Fleet Co…
Expand
2000
2000
FOSAMAX ® ( ALENDRONATE SODIUM TABLETS )
2000
Corpus ID: 53003647
FOSAMAX* (alendronate sodium) is a bisphosphonate that acts as a specific inhibitor of osteoclastmediated bone resorption…
Expand